---
figid: PMC4490961__nihms684782f2
figlink: /pmc/articles/PMC4490961/figure/F2/
number: Figure 2
caption: Interaction of the TFF2-CXCR4 axis with the active RAS-RAF-MEK-ERK pathway
  in the serrated pathway of colorectal cancer. Presently, cetuximab is an EGFR inhibitor
  approved for colorectal cancer. Clinical trials for the use of vemurafenib for BRAF
  V600E are ongoing. ERK refers to extracellular signal-regulated kinases.
pmcid: PMC4490961
papertitle: TFF2-CXCR4 Axis is Associated with BRAF V600E Colon Cancer.
reftext: Manish K. Gala, et al. Cancer Prev Res (Phila). ;8(7):614-619.
pmc_ranked_result_index: '40481'
pathway_score: 0.956452
filename: nihms684782f2.jpg
figtitle: Interaction of the TFF2-CXCR4 axis with the active RAS-RAF-MEK-ERK pathway
  in the serrated pathway of colorectal cancer
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4490961__nihms684782f2.html
  '@type': Dataset
  description: Interaction of the TFF2-CXCR4 axis with the active RAS-RAF-MEK-ERK
    pathway in the serrated pathway of colorectal cancer. Presently, cetuximab is
    an EGFR inhibitor approved for colorectal cancer. Clinical trials for the use
    of vemurafenib for BRAF V600E are ongoing. ERK refers to extracellular signal-regulated
    kinases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAPK1
  - CXCR4
  - MAP2K2
  - BRAF
  - ARAF
  - EGFR
  - MAPK3
  - HRAS
  - TFF2
  - RAF1
  - NRAS
  - EGF
  - KRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RẠF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RẠF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TFF2
  symbol: TFF2
  source: hgnc_symbol
  hgnc_symbol: TFF2
  entrez: '7032'
- word: RẠF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
